Liu Yuan, Cheng He Rossana, Munguba Gustavo C, Lee Richard K
Bascom Palmer Eye Institute, University of Miami Health System, Miami, FL, United States.
Department of Surgery, Mount Sinai Hospital, New York, NY, United States.
Front Neurosci. 2023 Oct 12;17:1227116. doi: 10.3389/fnins.2023.1227116. eCollection 2023.
Glaucoma is one of the main causes of irreversible visual field loss and blindness worldwide. Vision loss in this multifactorial neurodegenerative disease results from progressive degeneration of retinal ganglion cells (RGCs) and their axons. Identifying molecular markers that can be measured objectively and quantitatively may provide essential insights into glaucoma diagnosis and enhance pathophysiology understanding.
The chronic, progressive DBA/2J glaucomatous mouse model of glaucoma and C57BL6/J optic nerve crush (ONC) mouse model were used in this study. Changes in PVALB expression with RGC and optic nerve degeneration were assessed via gene expression microarray analysis, quantitative real-time polymerase chain reaction (qRT-PCR), Western blot and immunohistochemistry.
Microarray analysis of the retinal gene expression in the DBA/2J mice at different ages showed that the expression of PVALB was downregulated as the mice aged and developed glaucoma with retinal ganglion cell loss. Analysis of qRT-PCR results demonstrated PVALB at the mRNA level was reduced in the retinas and optic nerves of old DBA/2J mice and in those after ONC compared to baseline young DBA2/J mice. PVALB protein expression measured by Western blot was also significantly reduced signal in the retinas and optic nerves of old DBA/2J mice and those eyes with crushed nerves. Immunohistochemical staining results demonstrated that there were fewer PVALB-positive cells in the ganglion cell layer (GCL) of the retina and staining pattern changed in the optic nerve from old DBA/2J mice as well as in mice eyes following ONC.
PVALB is abundantly expressed both by RGCs' soma in the retinas and RGCs' axons in the optic nerves of C57BL/6J. Furthermore, the expression level of PVALB decreases with RGC degeneration in the glaucomatous DBA/2J mice and after ONC injury of C57BL6/6J, indicating that PVALB is a reliable RGC molecular marker that can be used to study retinal and optic nerve degeneration.
青光眼是全球不可逆视野缺损和失明的主要原因之一。这种多因素神经退行性疾病导致的视力丧失是由视网膜神经节细胞(RGCs)及其轴突的渐进性退变引起的。识别能够客观、定量检测的分子标志物,可能为青光眼诊断提供重要见解,并增进对病理生理学的理解。
本研究使用慢性进行性DBA/2J青光眼小鼠模型和C57BL6/J视神经挤压(ONC)小鼠模型。通过基因表达微阵列分析、定量实时聚合酶链反应(qRT-PCR)、蛋白质免疫印迹法和免疫组织化学法,评估视蛋白(PVALB)表达随RGC和视神经退变的变化。
对不同年龄DBA/2J小鼠视网膜基因表达的微阵列分析表明,随着小鼠年龄增长并出现伴有视网膜神经节细胞丢失的青光眼,PVALB的表达下调。qRT-PCR结果分析显示,与年轻的DBA2/J小鼠基线相比,老年DBA/2J小鼠以及ONC后的小鼠视网膜和视神经中,mRNA水平的PVALB降低。蛋白质免疫印迹法检测的PVALB蛋白表达在老年DBA/2J小鼠的视网膜和视神经以及神经挤压的眼中也显著降低。免疫组织化学染色结果表明,老年DBA/2J小鼠视网膜神经节细胞层(GCL)中PVALB阳性细胞较少,老年DBA/2J小鼠视神经以及ONC后小鼠眼中的染色模式也发生了变化。
在C57BL/6J小鼠中,PVALB在视网膜RGCs的胞体和视神经RGCs的轴突中均大量表达。此外,在青光眼DBA/2J小鼠和C57BL6/6J小鼠ONC损伤后,PVALB的表达水平随RGC退变而降低,表明PVALB是一种可靠的RGC分子标志物,可用于研究视网膜和视神经退变。